Navigation Links
Certain Skin Cancers More Common in HIV-Positive People
Date:2/1/2013

FRIDAY, Feb. 1 (HealthDay News) -- Non-melanoma skin cancers are more common among people who are HIV-positive, according to new research.

The study found that basal cell and squamous cell carcinomas, two of the most common forms of cancer in the United States, occur more than twice as often among those with HIV (the virus that causes AIDS).

The greater risk for cancer among people with HIV is likely due to immune system deficiency, the researchers said, and those with the virus should take extra precautions to protect and monitor their skin.

"The clinical implications for these findings include increased vigilance in skin-cancer screening for HIV-positive individuals, especially for squamous cell carcinomas and particularly for those who are not on antiretroviral therapy or who were diagnosed late and have more advanced HIV/AIDS," senior study author Dr. Maryam Asgari, a dermatologist and investigator at Kaiser Permanente's division of research, said in a Kaiser news release.

"HIV-positive individuals should also be advised to reduce behaviors that may further increase non-melanoma skin cancer incidence, such as excessive sun exposure," Asgari added.

The study, using data from 1996 to 2008, involved more than 6,500 HIV-positive patients and nearly 37,000 other patients who tested HIV-negative.

HIV-positive patients were more than twice as likely to develop basal cell carcinomas, the study revealed. They also were nearly three times more likely to be diagnosed with squamous cell carcinomas.

Patients with squamous cell carcinomas often had lower CD4 counts, which is a measure of immunodeficiency. The researches noted that previous treatment with antiviral therapy was not linked to either form of skin cancer.

Lead study author Michael Silverberg, also of Kaiser's division of research, said, "These findings represent unique data on non-melanoma skin cancers in HIV patients. Most cancer registries, on which previous studies relied, do not record these types of cancers."

"Given the increasing longevity for HIV-positive individuals, the burden of many age-related, non-AIDS-defining cancers, including [non-melanoma skin cancers], will only continue to increase," Silverberg said. "Based on our studies, non-melanoma skin cancers are by far the most common cancer this population experiences."

The findings have implications for changes in treatment, Asgari said.

"Given the observed association of immunodeficiency and squamous cell carcinomas, earlier initiation of antiretroviral therapy to maintain higher CD4 counts may also help reduce the burden of this cancer," she said.

More than 3.5 million new cases of non-melanoma skin cancers are diagnosed in the United States each year. Although most of these cases can be easily cured, many become locally invasive and destructive, according to the release.

The study, funded by research grants from Pfizer, Kaiser Permanente Northern California Community Benefit and the U.S. National Institutes of Health, was recently published online in the Journal of the National Cancer Institute.

More information

The American Cancer Society has more about skin cancer.

-- Mary Elizabeth Dallas

SOURCE: Kaiser Permanente, news release, Jan. 29, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
2. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
3. Codeine After Surgery Could Endanger Certain Kids: Study
4. Decision guide reduced uncertainty over breast cancer prevention, study finds
5. Certain Genetic Regions May Be Tied to Osteoporosis
6. Hot Flashes More Likely for Certain Smokers, Study Says
7. Early Study Hints at Link Between Certain Sunscreens, Endometriosis
8. Cabazitaxel can offer an advantage in certain patients
9. Antioxidant shows promise as treatment for certain features of autism, Stanford study finds
10. Gout Flare-ups Rise Sharply With Certain Foods: Study
11. Mouse Study Suggests Certain Fats Could Trigger Crohns, Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Certain Skin Cancers More Common in HIV-Positive People
(Date:7/25/2017)... ... July 25, 2017 , ... ... provider in the United States, today announced its partnership with financial technology company, ... , The foundation of the solution lies within Hyosung’s superior ATMs, assisted self-service ...
(Date:7/24/2017)... , ... July 24, 2017 , ... Engineers at the ... because it produces the same kind of electrical energy that the body uses. ... of moving electrons. This flow of electrons out of the battery is generated by ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... 2017 , ... Every year, thousands of dedicated Higher Education and K12 professionals ... is coupled with a dynamic theme like Camp Canvas; this year, they’ve managed to ... , To extend their partnership with Canvas beyond the LMS integration, Modo Labs ...
(Date:7/24/2017)... Solana Beach, California (PRWEB) , ... July 24, ... ... and commercialization of autologous fat (adipose) transfer systems announces the issuance of United ... (the ‘324 patent) for its adipose filtration technology. The '398 and '324 ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... 24, 2017 IBM (NYSE: IBM ) has ... for Solid-State Arrays (SSA) for the fourth year in a ... to Gartner, "Vendors in the Leaders quadrant have the highest ... A vendor in the Leaders quadrant has the market share, ... acceptance of new technologies. These vendors demonstrate a clear understanding ...
(Date:7/21/2017)... Did you know that PhRMA member companies invested $65.5 ... spending on brand medicines, generics and the supply chain account for ... just half of this (7 percent)? Or that the ... venture capital investments in high-growth biopharmaceutical startups? ... The biopharmaceutical ...
(Date:7/14/2017)... 14, 2017 Endo International plc (NASDAQ: ENDP ... 8, 2017.  Members of its senior management team will host a ... 8:30 a.m. ET. The dial-in number to access ... (678) 509-7598, and the passcode is 45397076. Please dial in 10 ... A replay of the call will be available ...
Breaking Medicine Technology: